Acadia Pharmaceuticals Inc is a biopharmaceutical company based in San Diego, California, dedicated to developing and commercializing innovative medicines for central nervous system disorders and rare diseases. Its flagship product, NUPLAZID, treats hallucinations and delusions associated with Parkinson’s disease psychosis. Acadia is also advancing treatments for conditions like Rett Syndrome, schizophrenia, Prader-Willi syndrome, and Alzheimer’s disease psychosis, among others. The company, originally named Receptor Technologies, was founded in 1993 and emphasizes addressing unmet medical needs in neuropsychiatric conditions.
Wednesday's top analyst upgrades and downgrades included Amazon.com, Arm, Corning, Dollar General, Electronic Arts, Estee Lauder, Juniper Networks, Next Era Energy Partners, Realty Income, Rivian Automotive, Sabra Healthcare REIT and Starwood Property…
Friday's additional top analyst upgrades and downgrades included Acadia Pharmaceuticals, BioCryst Pharmaceuticals, Duke Energy, Kellogg, Paramount Global, Rhythm Pharmaceuticals and Teva Pharmaceutical Industries.
Citigroup takes a look at a couple stocks with potentially huge upside and where they could go in light of a possible recession.
Wednesday's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Chevron, Compass, ConocoPhillips, Kraft Heinz, Micron Technology, Netflix, Nike, Seagate Technology, Shoals Technologies and WestRock.
Tuesday's additional top analyst upgrades and downgrades included Acadia Pharmaceuticals, CarGurus, CubeSmart, Etsy, Keurig Dr Pepper and Molson Coors Beverage.
Friday's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Accenture, Amgen, AutoZone, Azek, Boeing, Dollar General, Etsy, Fidelity National Information Services, FedEx, NexTier Oilfield Solutions, S&P Global, Unity Software and Warner Bros.…
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Constellation Energy, Edwards Lifesciences, Host Hotels & Resorts, Johnson & Johnson and Magna International.
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Enphase Energy, General Motors, Incyte, Lyft, MP Materials, Newmont, Tenet Healthcare and Vale.
Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum, Peloton Interactive, Pfizer, Salesforce.com and 3M.
Wednesday's early top analyst upgrades and downgrades included Biogen, Goodyear Tire, Hippo, Krispy Kreme, Lockheed Martin, Micron Technology, Microsoft, Nike and Patterson-UTI Energy.
Tuesday afternoon's top analyst upgrades and downgrades included Boot Barn, Cigna, Comerica, GoodRx, Oracle and United Rentals.
Monday afternoon's analyst upgrades and downgrades included Bristol-Myers Squibb, Intel, Merck, Newell Brands, Snap, Spotify Technology and Tilray.
Thursday afternoon's analyst upgrades and downgrades included Deere, NetApp, Petrobras and TJX Companies.
JMP Securities has come out with a few stock picks that it thinks will outperform in the coming months.
Tuesday's top analyst upgrades and downgrades included Airbnb, Chevron, Coupang, Freeport-McMoRan, Peloton Interactive, Snap, Wynn Resorts and Zillow.
